Gtc Biotherapeutics Inc: Premium Company Profile

Publication Date	January 2008
Publisher	Datamonitor
Product Type	Databook
Pages	48
ISBN Number	not applicable
Product Code	DAT09412

Price

£265.00
approximately: $521 | €337

PRINT £265 ($521 | €337)

Order above formats by FAX

Summary

Introduction

GTC Biotherapeutics is engaged in the development, production and commercialization of therapeutic proteins expressed and purified from the milk of transgenic animals such as goats and cattle. ATryn, the company's major product, is a recombinant human antithrombin produced in the milk of transgenic goats.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

GTC develops, produces, and commercializes therapeutic proteins through transgenic animal technology. In addition to ATryn, GTC is working with LFB Biotechnologies to develop recombinant forms of human factor VIIa and a CD20 monoclonal antibody.

Total revenues of the company witnessed decline at a CAGR of 11% during 2002-2006, from $10 million to $6 million. It derives its revenues from collaborative agreements which include non-refundable license fees, funding of research and development, payments based upon the achievement of certain milestones and royalties.

Between 2006 and 2010, the company's revenues are forecasted to increase at a CAGR of 22% from $6 million to $13 million. There will be an absolute growth of +$7 million in the company's total revenues by 2010. The company is expected to receive all of its revenues through collaborative agreements with its partners.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Pipeline Products
- AC Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Manufacturing
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: GTC Biotherapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 1: GTC Biotherapeutics - Key Facts
- Table 2: GTC Biotherapeutics - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 3: GTC Biotherapeutics - Key Events Impacting Share Price Performance
- Table 4: GTC Biotherapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 5: GTC Biotherapeutics - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 6: GTC Biotherapeutics - Balance Sheet, 2002-2006 ($ Mn)
- Table 7: GTC Biotherapeutics - Cash Flow, 2002-2006 ($ Mn)
- Table 8: GTC Biotherapeutics - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 9: GTC Biotherapeutics - in-house Pipeline Products
- Table 10: GTC Biotherapeutics - Collaboration Pipeline
- Table 11: GTC Biotherapeutics- Key Strategic Revenues, 2006-2010 ($ Mn)
- Table 12: GTC Biotherapeutics - Key Competitors
- Table 13: GTC Biotherapeutics - Key Suppliers
- Table 14: GTC Biotherapeutics - Key Clients
- Table 15: GTC Biotherapeutics - Key Shareholders
- Table 16: GTC Biotherapeutics - SWOT Analysis Summary
- Table 17: GTC Biotherapeutics - Value Chain Analysis
- Table 18: GTC Biotherapeutics - Scorecard
- Table 19: GTC Biotherapeutics - Key Employees
- Table 20: GTC Biotherapeutics - Financial and Operational Overview